# Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)

> **NCT02864147** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 134 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Dysplasia

## Interventions

- **DRUG:** 9-valent HPV vaccine
- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT02864147
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2022-05-24
- **Final completion:** 2022-11-22
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864147, "Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02864147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*